Premier Insights Archive | Page 2 of 3 | Premier Research

Premier Insight 202 | Optimizing the Market Value of an Asset with Multiple Potential Indications

Premier Insight 204 | Expediting Regulatory Decisions: Coordinating Dual Active Substance Master File (ASMF) Submissions

Premier Insight 282 | Leveraging the Power of Communication: Supporting Enrollment of a Phase 2 Cervical Cancer Study During a Pandemic

Premier Insight 281: Overcoming Enrollment Challenges in a Phase 2 Prostate Cancer Clinical Trial

Resource Document: 8 New Elements of the IVDR

Premier Insight 278: A Decade-Long Partnership Culminates in FDA Approval

Premier Insight 280: Engineering a PMA Study

Premier Insight 279: Executing a Dual-Submission Study

Premier Insight 277: Optimizing Enrollment for a Phase 3 Clinical Trial During a Global Pandemic

Premier Insight 274: Site Selection, Manufacturing, and Long-Term Follow-Up in a Transition Phase 1/2 Gene Therapy Trial